• Study of Tebentafusp for Patients with Metastatic Uveal Melanoma and Resectable Liver Metastasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain
  • Study of Ravulizumab to Prevent Delayed Graft Function in Adult Patients After Kidney Transplant

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia France Germany Italy Poland +2
  • Long-Term Safety Study of Plozasiran for Adults with High Triglycerides

    Recruiting

    3 1 1
    Investigated Diseases:
    Belgium Bulgaria Croatia Czechia France Germany +8
  • Study on the Safety and Effectiveness of OMTX705 with Regorafenib and Tislelizumab for Patients with Advanced Colorectal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Spain
  • Study of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Austria Belgium Bulgaria Czechia Denmark France +9
  • Study on the Safety and Effectiveness of Bexicaserin for Seizures in Children and Adults with Developmental and Epileptic Encephalopathy

    Recruiting

    3 1
    Investigated Diseases:
    Belgium Finland France Germany Italy Latvia +3
  • Study Comparing BGB-16673 to Drug Combinations for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Treated with BTK and BCL2 Inhibitors

    Recruiting

    3 1 1 1
    Czechia Germany Italy The Netherlands Poland
  • Study of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Denmark France Germany Italy The Netherlands +5
  • Study on the Safety and Effectiveness of Sovateltide for Patients with Acute Ischemic Stroke

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain
  • Study of Acalabrutinib with R-CHOP for Patients with Untreated Mantle Cell Lymphoma in Spain

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

powered by